# Photodynamic Therapy for Papulopustular Rosacea

> **NCT02075671** · PHASE4 · COMPLETED · sponsor: **George Washington University** · enrollment: 30 (actual)

## Conditions studied

- Rosacea
- Papulopustular Rosacea

## Interventions

- **DRUG:** Aminolevulinic acid topical solution 20%
- **DEVICE:** Blu-U Light Therapy
- **OTHER:** Placebo vehicle only

## Key facts

- **NCT ID:** NCT02075671
- **Lead sponsor:** George Washington University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-24
- **Primary completion:** 2019-08-15
- **Final completion:** 2019-08-15
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02075671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02075671, "Photodynamic Therapy for Papulopustular Rosacea". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02075671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*